What is Ventrk?
Ventrk is a technology company focused on developing software solutions designed to empower better decision-making and drive improved results, ultimately fostering a stronger and healthier lifestyle. Its core offering, the TheraCentric platform, is engineered to streamline practice activities and enhance patient engagement within the therapy management space. This strategic focus addresses a critical need for efficiency and effectiveness in healthcare delivery.
How much funding has Ventrk raised?
Ventrk has raised a total of $1.9M across 2 funding rounds:
Angel/Seed
$900K
Unspecified
$1M
Angel/Seed (2022): $900K, investors not publicly disclosed
Unspecified (2022): $1M led by HBSI Capital
Key Investors in Ventrk
HBSI Capital
HBSI Capital is a firm focused on organizational growth, providing both investment and management consulting. They prefer to work with existing leadership and offer board-level guidance, with an option for on-the-ground support and mentorship for executive teams.
What's next for Ventrk?
The substantial enterprise-level funding Ventrk has recently acquired signals a pivotal moment for the company, likely enabling accelerated product development, market expansion, and enhanced operational capabilities. This capital infusion is expected to fuel strategic initiatives aimed at solidifying its market position and scaling its innovative TheraCentric platform. Future growth will likely involve deepening its technological capabilities and broadening its reach within the health and wellness technology sector.
See full Ventrk company page
